John R. Murphy - 04 Oct 2023 Form 4 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Director
Signature
/s/ John R. Murphy
Issuer symbol
CVKD
Transactions as of
04 Oct 2023
Net transactions value
+$13,973
Form type
4
Filing time
06 Oct 2023, 17:32:57 UTC
Previous filing
02 Oct 2023
Next filing
02 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVKD Common Stock Purchase $12,132 +17,331 +2.9% $0.7000 612,123 04 Oct 2023 Direct
transaction CVKD Common Stock Purchase $1,842 +2,669 +0.44% $0.6900 614,792 05 Oct 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.